Journal article

The Involvement of Sortilin/NTSR3 in Depression as the Progenitor of Spadin and Its Role in the Membrane Expression of TREK-1

Frontiers in pharmacology, 2018. Mazella J, Borsotto M, Heurteaux C.

Study type

Journal article

Subjects

Not classified in PubMed MeSH

Journal

Frontiers in pharmacology

Published

2018

PubMed

PMID 30670975 ↗

DOI

10.3389/fphar.2018.01541 ↗

Full text

Free on PubMed Central (PMC6331531) ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

PE-22-28 →

Other papers on PE-22-28

Review · 2019

Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin

Journal article · 2021

Genetic and pharmacological inhibition of two-pore domain potassium channel TREK-1 alters depression-related behaviors and neuronal plasticity in the hippocampus in mice

Journal article · 2017

Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page